Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples

Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients

(2018) Cristina Miglis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr -Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution

(2017) Ka Lip Chew et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

(2016) Maria Helena Rigatto et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

(2016) Alexandre P. Zavascki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency

(2016) Visanu Thamlikitkul et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods

(2015) Brian C. Nelson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study

(2015) Maria Helena Rigatto et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy

(2014) K. Phe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?

(2014) R. L. Nation et al.   CLINICAL INFECTIOUS DISEASES

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

(2013) Ana M. Sandri et al.   CLINICAL INFECTIOUS DISEASES

Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center

(2013) Darowan S. Akajagbor et al.   CLINICAL INFECTIOUS DISEASES

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

(2013) Felipe F. Tuon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

High Performance Liquid Chromatography–Mass Spectrometry Assay for Polymyxin B1 and B2 in Human Plasma

(2012) Tiffany A. Thomas et al.   THERAPEUTIC DRUG MONITORING

Pharmacokinetics of Polymyxin B in a Patient With Renal Insufficiency: A Case Report

(2011) A. L. H. Kwa et al.   CLINICAL INFECTIOUS DISEASES

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

(2011) N. Gupta et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

(2008) Alexandre P. Zavascki et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections

(2007) Andrea L.H. Kwa et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE